The Spanish Biosimilar Medicines Association (BIOSIM) welcomes the opportunity to comment and give feedback on the document (Combined Evaluation Roadmap/Inception Impact Assessment) about the Evaluation and revision of the EU general pharmaceuticals legislation.
